Saint Luke's Cancer Institute
@SLCI_KC
Followers
31
Following
25
Media
11
Statuses
36
Saint Luke's Cancer Institute provides early detection, expert diagnosis, personalized treatment options, and survivorship support to every patient.
Kansas City, MO
Joined January 2023
Congratulations to Rich Liekweg, BJC Health System CEO, who announced his plans to retire on October 1, 2025. BJC is pleased to announce that Nick Barto, current BJC Health System President, will succeed Rich as President and CEO of BJC Health System:
0
0
0
Saint Luke’s Cancer Institute is featured in ACCC’s new video series on using genomics to expand access to clinical trials. Watch the series from ACCC for more on how our team is advancing the future of cancer care:
0
0
0
Saint Luke's Cancer Institute's new Comprehensive Cancer Program is now open on the campus of Saint Luke's North Hospital-Barry Road! 🎉 . Take an inside look with Dan and Dr. Zach Nicholas, Director of Radiation Oncology, to see all this expanded space has to offer.
0
0
0
RT @MarcRothMD: #ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! @Meddoc77 (Himil Mahadevia) and Parth Sharma. Co….
0
7
0
RT @MarcRothMD: #ASCO25 Day 1: it was great getting the @SLCI_KC crew together outside of the office to catch up! @saintlukeskc
https://t.c….
0
2
0
RT @MarcRothMD: Happy to work in a practice with great people that enjoy blowing off some steam at the end of the week. Cheers to many mor….
0
2
0
RT @MarcRothMD: Calling all thoracic oncologists - Saint Luke’s in Kansas City is hiring! We have robust precision and research programs.….
0
1
0
RT @FightCRC: Join us alongside gastrointestinal medical oncologist @MarcRothMD of @StLukesSTL April 25 at 1pm EST for a deep dive into bio….
0
1
0
We’re excited to announce the recent opening of PRISM-1 via @arcusbio, a P3 trial for pts with met pancreatic cancer! Trial is exploring gem/abraxane +/- quemliclustat. Oncology needs panc trials! 👏 👏👏@saintlukeskc .
0
0
0
RT @ParthDSharma: Thrilled to present our research at @ASCO #GI25 highlighting the efficacy of HER-2 targeted therapies in #biliarytractcan….
0
2
0
RT @ParthDSharma: Thrilled to share that our research project has been accepted for poster presentation at #ASCOGI25!!!.Grateful to my ment….
0
1
0
RT @BPonvilawan: Our correspondence is now available on @TheLancet!. Differences in HCC etiology may contribute to the positive result of c….
0
3
0
RT @BPonvilawan: More than happy to have a review on predictive biomarkers for irAE. Prospective studies that capture irAE proactively bett….
0
1
0
RT @MarcRothMD: As #PancreaticCancerAwarenessMonth comes to a close, I wanted to highlight some of our amazing @SLCI_KC #GI #Cancer team m….
0
1
0
RT @MarcRothMD: The day we’ve been waiting for! @US_FDA approves fruquitinib for refractory met #colorectal #cancer providing another optio….
0
1
0
RT @MarcRothMD: Check out our new case report on a patient w #colorectal #cancer and a T790M mutation who responded to targeted therapy w o….
0
2
0
📢 New provider spotlight: We're excited to welcome Norin Ansari MD MPH to Saint Luke's Cancer Institute! She comes from @YaleCancer @YaleHemOnc fellowship and is happy to back home in the Midwest. Dr. Ansari is seeing new patients at @SLCI_KC East in Lee's Summit, MO. Welcome!🤗
0
1
8
St Luke's precision oncology program reports improved outcomes for patients with @saintlukeskc molecular tumor board-directed therapy at the ESMO conference in Madrid
0
1
4
Dr. Bansal keeps his ongoing research into patient subgroups that benefit from immunotherapy. Being presented at @sitcancer 2023 annual conference.
0
0
1
